New drugs and combinations in haematological cancers improve complete remission rates

Bookmark and Share
Published: 1 Nov 2016
Views: 1963
Dr Paolo Corradini - University of Milan, Milan, Italy

Dr Corradini talks to ecancertv at ICMM 2016 about the new drugs emerging for treating various haematological cancers.

He discusses both three and four-drug combinations as well as new antibodies such as daratumumab and elotuzumab.

The complete remission rate is of high importance, he stresses, and has seen much improvement in recent years, especially in younger patients.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.